Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V3-P in Inoperable Pancreatic Cancer
NCT03165591Phase 2Unknown
- Sponsor
- Immunitor Inc.
- Start
- May 2017
- Primary completion
- Feb 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of V3-P in pancreatic ductal adenocarcinoma (PDAC), sponsored by Immunitor Inc.. Status: unknown.
02
Drugs
V3-P
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT03165591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03165591.